Crown Bioscience is set to display significant advances in preclinical and translational oncology research at a prominent cancer research meeting, AACR 2024. The company's contributions to the cont...
With this approval, the MEBGEN™ BRAF 2 Kit is expected to contribute to the timely personalized treatment for patients with radically unresectable thyroid cancer based on the presence or absence of...
The new facility expands the company’s capacity to support both global and local biotech and pharma companies engaged in preclinical and translational oncology drug discovery and development.
JSR Life Sciences announced that its lead product, Amsphere™ A3 has been incorporated for the first time into the commercial manufacturing of an FDA-approved treatment
This project will conduct R&D aimed at the establishment and practical application of a wide range of fundamental technologies related to intestinal microbiome drug discovery for the creation of in...
MBL donated 20,000 their SARS-CoV-2 antigen test kits "GLINE-2019-nCoV Ag kit" to Ina City, Nagano Prefecture, where their research and production facilities are located